![]() ![]() ‘Pro-choice & pro-woman arguments are b-’ "Government-imposed bans or restrictions on the use of embryos or hES cells in research and development in the United States and abroad could generally constrain stem cell research, thereby limiting the market and demand for our products," the company stated. In a March 9 filing with the SEC covering company activity in 2022, Lineage Cell Therapeutics briefly addressed embryonic stem cells. “The company is not able to contribute to your report on the personal financial investments of federal government officials,” spokesman Nic Johnson wrote in an email. Lineage Cell Therapeutics declined to answer questions about its technology, use of embryonic stem cells or investments in the company by government officials. Heipel did not respond to several follow-up questions, including why Luna's husband purchased Lineage Cell Therapeutics stock, what she thinks of her husband's stock holding and whether he plans to sell it. ![]() The day after publication of this article, Luna spokeswoman Edie Heipel said in an email to Raw Story that "Rep Luna’s positions on this issue are blatantly clear" and that "she has no and has never had affiliation" with Lineage Cell Therapeutics "to include owning stock". In a phone call Monday, Luna congressional press aide Darren Dershem acknowledged Raw Story’s several requests for comment, but Luna’s office did not otherwise respond to messages and emailed questions. And frankly, if you're going to do human testing, that makes us no better than the Nazis." It's morally wrong,” Luna continued, citing the sale of pre-birth tissues for research purposes. So I feel like that whole argument in itself is really disturbing, because at the end of the day, you know, where are they getting this tissue? “There's other stem cells that they can use. "A lot of times doctors and scientists will argue, well, 'we need stem cells.' Well, you don't have to have necessarily fetal stem cells,” Luna said during an interview in 2021 with One America News. Luna herself has previously questioned the use of certain human stem cells in medical research. That, according to corporate filings with the Securities and Exchange Commission, includes the use of embryonic stem cells derived from human embryos - a practice that many conservatives consider morally fraught, if not reprehensible, amid an age-old debate over the definition of personhood and when life truly begins. The California-based company says it intends to “pioneer a new branch of medicine based on transplanting specific cell types to patients with serious medical conditions,” such as paralysis, using proprietary technology and therapies. The congressional financial disclosures indicate that Andrew Gamberzky, Luna’s husband, holds a stock investment worth between $1,001 and $15,000 in Lineage Cell Therapeutics. Anna Paulina Luna (R-FL), one of Congress’ most outspoken abortion rights opponents, disclosed that her husband invests in a company that utilizes human embryonic stem cells to treat disabilities, a Raw Story review of congressional financial documents. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |